Ahmed AR, Lappin D. Oral alkali therapy and the management of metabolic acidosis of chronic kidney disease: A narrative literature review. World J Nephrol. 2018;7(6):117-22. PubMed Länk till annan webbplats.
Goraya N, Wesson DE. Management of the Metabolic Acidosis of Chronic Kidney Disease. Adv Chronic Kidney Dis. 2017;24(5):298-304. PubMed Länk till annan webbplats.
Hu MK, Witham MD, Soiza, RL. Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Clin. Med. 2019, 8, 208. PubMed Länk till annan webbplats. Fulltext Länk till annan webbplats.
Dubey AK, Sahoo J, Vairappan B, Haridasan S, Parameswaran S, Priyamvada PS. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial. Nephrol Dial Transplant. 2020;35(1):121-9. PubMed Länk till annan webbplats.
Gaggl M, Repitz A, Riesenhuber S, Aigner C, Sliber C, Fraunschiel M, Cejka D, Sunder-Plassmann G. Effect of Oral Sodium Bicarbonate Treatment on 24-Hour Ambulatory Blood Pressure Measurements in Patients With Chronic Kidney Disease and Metabolic Acidosis. Front Med (Lausanne). 2021 Sep 6;8:711034. Länk till annan webbplats.
Hultin S, Hood C, Campbell KL, Toussaint ND, Johnson DW, Badve SV. A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes. Kidney Int Rep. 2020 Dec 31;6(3):695-705 Länk till annan webbplats.
Shi H, Su X, Yan B, Li C, Wang L. Effects of orala alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: asystematic review and meta-analysis. Renal failure. 2022, vol 44 (1), 106-115 Länk till annan webbplats..

Metabol acidos